Literature DB >> 7553871

Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA 1.

A Bochkarev1, J A Barwell, R A Pfuetzner, W Furey, A M Edwards, L Frappier.   

Abstract

The crystal structure of the DNA-binding and dimerization domains of the Epstein-Barr virus nuclear antigen 1 (EBNA1), which binds to and activates DNA replication from the latent origin of replication in Epstein-Barr virus, was solved at 2.5 A resolution. EBNA1 appears to bind DNA via two independent regions termed the core and the flanking DNA-binding domains. The core DNA-binding domain, which comprises both the dimerization domain and a helix predicted to bind the inner portion of the EBNA1 DNA recognition element, was remarkably similar to the structure of the papillomavirus E2 protein, despite a complete lack of sequence conservation. The flanking DNA-binding domain, only a portion of which is contained in the current structure, consists in part of an alpha helix whose N-terminus contacts the outer regions of the EBNA1 DNA recognition element.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553871     DOI: 10.1016/0092-8674(95)90232-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  65 in total

1.  Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus.

Authors:  D F Ceccarelli; L Frappier
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Epstein-Barr nuclear antigen 1 binds and destabilizes nucleosomes at the viral origin of latent DNA replication.

Authors:  T M Avolio-Hunter; P N Lewis; L Frappier
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

3.  Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.

Authors:  Hong Wu; Priya Kapoor; Lori Frappier
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1.

Authors:  John Sears; John Kolman; Geoffrey M Wahl; Ashok Aiyar
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  KSHV but not MHV-68 LANA induces a strong bend upon binding to terminal repeat viral DNA.

Authors:  Rajesh Ponnusamy; Maxim V Petoukhov; Bruno Correia; Tania F Custodio; Franceline Juillard; Min Tan; Marta Pires de Miranda; Maria A Carrondo; J Pedro Simas; Kenneth M Kaye; Dmitri I Svergun; Colin E McVey
Journal:  Nucleic Acids Res       Date:  2015-09-30       Impact factor: 16.971

7.  Structures of capsid and capsid-associated tegument complex inside the Epstein-Barr virus.

Authors:  Wei Liu; Yanxiang Cui; Caiyan Wang; Zihang Li; Danyang Gong; Xinghong Dai; Guo-Qiang Bi; Ren Sun; Z Hong Zhou
Journal:  Nat Microbiol       Date:  2020-07-27       Impact factor: 17.745

8.  Nuclear import of Epstein-Barr virus nuclear antigen 1 mediated by NPI-1 (Importin alpha5) is up- and down-regulated by phosphorylation of the nuclear localization signal for which Lys379 and Arg380 are essential.

Authors:  Ryo Kitamura; Toshihiro Sekimoto; Sayuri Ito; Shizuko Harada; Hideo Yamagata; Hisao Masai; Yoshihiro Yoneda; Kazuo Yanagi
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 9.  Viral proteomics.

Authors:  Karen L Maxwell; Lori Frappier
Journal:  Microbiol Mol Biol Rev       Date:  2007-06       Impact factor: 11.056

10.  In situ proteolysis for protein crystallization and structure determination.

Authors:  Aiping Dong; Xiaohui Xu; Aled M Edwards; Changsoo Chang; Maksymilian Chruszcz; Marianne Cuff; Marcin Cymborowski; Rosa Di Leo; Olga Egorova; Elena Evdokimova; Ekaterina Filippova; Jun Gu; Jennifer Guthrie; Alexandr Ignatchenko; Andrzej Joachimiak; Natalie Klostermann; Youngchang Kim; Yuri Korniyenko; Wladek Minor; Qiuni Que; Alexei Savchenko; Tatiana Skarina; Kemin Tan; Alexander Yakunin; Adelinda Yee; Veronica Yim; Rongguang Zhang; Hong Zheng; Masato Akutsu; Cheryl Arrowsmith; George V Avvakumov; Alexey Bochkarev; Lars-Göran Dahlgren; Sirano Dhe-Paganon; Slav Dimov; Ludmila Dombrovski; Patrick Finerty; Susanne Flodin; Alex Flores; Susanne Gräslund; Martin Hammerström; Maria Dolores Herman; Bum-Soo Hong; Raymond Hui; Ida Johansson; Yongson Liu; Martina Nilsson; Lyudmila Nedyalkova; Pär Nordlund; Tomas Nyman; Jinrong Min; Hui Ouyang; Hee-won Park; Chao Qi; Wael Rabeh; Limin Shen; Yang Shen; Deepthi Sukumard; Wolfram Tempel; Yufeng Tong; Lionel Tresagues; Masoud Vedadi; John R Walker; Johan Weigelt; Martin Welin; Hong Wu; Ting Xiao; Hong Zeng; Haizhong Zhu
Journal:  Nat Methods       Date:  2007-11-04       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.